Turnstone Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TSBX and buy or sell other stocks, ETFs, and their options commission-free!About TSBX
Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It engages in the business of developing and commercializing therapeutics.
CEOSammy J. Farah, PhD, MBA
CEOSammy J. Farah, PhD, MBA
Employees14
Employees14
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2015
Founded2015
Employees14
Employees14
TSBX Key Statistics
Market cap8.21M
Market cap8.21M
Price-Earnings ratio-0.17
Price-Earnings ratio-0.17
Dividend yield—
Dividend yield—
Average volume89.33K
Average volume89.33K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.8085
52 Week high$0.8085
52 Week low$0.29
52 Week low$0.29
Stock Snapshot
As of today, Turnstone Biologics(TSBX) shares are valued at $0.36. The company's market cap stands at 8.21M, with a P/E ratio of -0.17.
On 2025-12-12, Turnstone Biologics(TSBX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Turnstone Biologics(TSBX) stock has reached 0, versus its average volume of 89.33K.
Over the past 52 weeks, Turnstone Biologics(TSBX) stock has traded between a high of $0.81 and a low of $0.29.
Over the past 52 weeks, Turnstone Biologics(TSBX) stock has traded between a high of $0.81 and a low of $0.29.
People also own
Based on the portfolios of people who own TSBX. This list is generated using Robinhood data, and it’s not a recommendation.